The percentage of short-stay residents who are receiving an antipsychotic medication during the target period but not on their initial assessment.

Number of Short-stay residents for whom one or more assessments indicates that antipsychotic medication was received

All short-stay residents who do not have exclusions and who meet all of the following conditions: 1. The resident has a target assessment, and 2. The resident has an initial assessment, and 3.The target assessment is not the same as the initial assessment.

Residents with Schizophrenia, Tourette's syndrome, Huntington's disease, The resident's initial assessment indicates antipsychotic medication use or antipsychotic medication use is unknown.

None

Data collected as part of Minimum Data Set (MDS) which is the federally mandated process for clinical assessment of all residents in Medicare and Medicaid certified nursing homes. This process provides a comprehensive assessment of each resident's functional capabilities and helps nursing home staff identify health problems. MDS assessments are completed for all residents in certified nursing homes, regardless of source of payment for the individual resident. MDS assessments are required for residents on admission to the nursing facility, periodically, and on discharge. All assessments are completed within specific guidelines and time-frames. In most cases, participants in the assessment process are licensed health care professionals employed by the nursing home. MDS information is transmitted electronically by nursing homes to the national MDS database at CMS.

Online at Medicare's compare sites, www.medicare.gov/care-compare/?providerType=NursingHome,

www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/nursinghomequalityinits/nhqiqualitymeasures